Brief: Cortexyme Successfully Completes Phase 1 Single And Multiple Ascending Dose Clinical Trial Of COR588

IRulya Therapeutics

27/07/2022 13:38

July 27 (Reuters) - Cortexyme Inc  CRTX.O :
    * CORTEXYME SUCCESSFULLY COMPLETES PHASE 1 SINGLE AND
MULTIPLE
ASCENDING DOSE CLINICAL TRIAL OF COR588

Source text for Eikon:  ID:nBwbkkn5Pa 
Further company coverage:  CRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))